secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2022-12-14T23:59:59+00:00
Accession:  0001193125-22-304849
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma terminates at-the-market sales agreement with Jefferies LLC
-------------------------------------------------------------------------

- Notice of termination given December 9, 2022; effective December 22, 2022.
- Sales agreement allowed at-the-market offerings of common stock through Jefferies.
- Through termination, 856,030 shares sold for net proceeds of $4.3 million.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522304849/0001193125-22-304849-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522304849/d438125d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-304849

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer